[HTML][HTML] First-dose mRNA vaccination is sufficient to reactivate immunological memory to SARS-CoV-2 in subjects who have recovered from COVID-19
…, M Spinicci, L Zammarchi, ST Kiros… - The Journal of …, 2021 - Am Soc Clin Investig
The characterization of the adaptive immune response to COVID-19 vaccination in individuals
who recovered from SARS-CoV-2 infection may define current and future clinical practice. …
who recovered from SARS-CoV-2 infection may define current and future clinical practice. …
[HTML][HTML] SARS-CoV-2 infection and vaccination trigger long-lived B and CD4+ T lymphocytes with implications for booster strategies
…, M Spinicci, G Lamacchia, ST Kiros… - The Journal of …, 2022 - Am Soc Clin Investig
BACKGROUND Immunization against SARS-CoV-2, the causative agent of COVID-19, occurs
via natural infection or vaccination. However, it is currently unknown how long infection- or …
via natural infection or vaccination. However, it is currently unknown how long infection- or …
Cell‐mediated and humoral adaptive immune responses to SARS‐CoV‐2 are lower in asymptomatic than symptomatic COVID‐19 patients
The characterization of cell‐mediated and humoral adaptive immune responses to SARS‐CoV‐2
is fundamental to understand COVID‐19 progression and the development of …
is fundamental to understand COVID‐19 progression and the development of …
[HTML][HTML] Clinical and immunological features of SARS-CoV-2 breakthrough infections in vaccinated individuals requiring hospitalization
…, A Carnasciali, P Farahvachi, A Rocca, ST Kiros… - Journal of Clinical …, 2022 - Springer
Background and Purpose Waning immunity and the surge of SARS-CoV-2 variants are
responsible for breakthrough infections, ie, infections in fully vaccinated individuals. Although the …
responsible for breakthrough infections, ie, infections in fully vaccinated individuals. Although the …
[HTML][HTML] Impaired response to first SARS‐CoV‐2 dose vaccination in myeloproliferative neoplasm patients receiving ruxolitinib
…, A Mazzoni, L Maggi, ST Kiros… - American journal of …, 2021 - ncbi.nlm.nih.gov
To the Editor: Covid-19, the disease caused by pandemic SARS-CoV-2 infection, had
significant impact on patients with hematologic conditions1; a metaanalysis involving 3377 …
significant impact on patients with hematologic conditions1; a metaanalysis involving 3377 …
Heterogeneous magnitude of immunological memory to SARS‐CoV‐2 in recovered individuals
…, M Spinicci, L Salvati, S Tekle Kiros… - Clinical & …, 2021 - Wiley Online Library
Objective Although the adaptive immune response to SARS‐CoV‐2 has been characterised
in the acute and early convalescent phase of the disease, few studies explore whether …
in the acute and early convalescent phase of the disease, few studies explore whether …
[HTML][HTML] Bendamustine impairs humoral but not cellular immunity to SARS-CoV-2 vaccination in rituximab-treated B-cell lymphoma–affected patients
…, M Capone, S Francalanci, ST Kiros… - Frontiers in …, 2023 - frontiersin.org
Background Patients with B-cell lymphoma are a fragile category of subjects, particularly
exposed to infections and characterized by an impaired vaccination response due to the …
exposed to infections and characterized by an impaired vaccination response due to the …
[HTML][HTML] Long-term SARS-CoV-2 asymptomatic carriage in an immunocompromised host: clinical, immunological, and virological implications
…, L Graziani, N Di Lauria, V Di Pilato, ST Kiros… - Journal of clinical …, 2022 - Springer
Purpose SARS-CoV-2 infection in immunocompromised hosts is challenging, and prolonged
viral shedding can be a common complication in these patients. We describe the clinical, …
viral shedding can be a common complication in these patients. We describe the clinical, …
[HTML][HTML] Effects of viremia and CD4 recovery on gut “microbiome-immunity” axis in treatment-naïve HIV-1-infected patients undergoing antiretroviral therapy
…, G Nannini, G Sterrantino, ST Kiros… - World Journal of …, 2022 - ncbi.nlm.nih.gov
BACKGROUND Human immunodeficiency virus type 1 (HIV-1) infection is characterized by
persistent systemic inflammation and immune activation, even in patients receiving effective …
persistent systemic inflammation and immune activation, even in patients receiving effective …
[HTML][HTML] Fourth dose of mRNA COVID-19 vaccine transiently reactivates spike-specific immunological memory in people living with HIV (PLWH)
Background: People Living With HIV (PLWH), with advanced disease, lower CD4+ T cell
counts or an unsuppressed HIV viral load can have a suboptimal vaccine response. For this …
counts or an unsuppressed HIV viral load can have a suboptimal vaccine response. For this …